Read & Publish Open Access Agreement between The Company of Biologists and MALMAD renewed for a further three years

Following the success of our previous collaborations, we’ve entered into a new agreement that will be in effect from 1 January 2026 through 31 December 2028. 

Researchers at eight leading institutions in Israel can continue to publish an uncapped number of research articles immediately Open Access (OA) in our transformative journals (Development, Journal of Cell Science and Journal of Experimental Biology) and our fully Open Access journals (Disease Models & Mechanisms and Biology Open) without paying an article processing charge (APC). Authors at participating institutions also benefit from unlimited access to our transformative journals, including their full archives dating back to 1853. 

Read the full announcement here.